Nellcor gets US go-ahead for non-critical monitoring
This article was originally published in Clinica
Executive Summary
The first two components of Nellcor's Symphony modular monitoring system for use in non-critical-care settings have been cleared for sale in the US. The N-3000 pulse oximeter and N-3100 non-invasive blood pressure monitor work as standalone systems or as one unit, and work with any combination of Symphony modules. Nellcor has designed the Symphony modular system to address the shift to monitoring in the hospital ward, alternate care sites and mobile settings.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.